This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Ocugen Inc. (OCGN) slid 6.91% to $7.14 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 2.04% to 4,352.63 and Dow Jones Industrial Average falling 1.63% to 34,299.99. Ocugen Inc. closed $11.63 short of its 52-week high ($18.77), which the company reached on February 8th.
The stock underperformed when compared to some of its competitors Tuesday, as Adverum Biotechnologies Inc. (ADVM) fell 3.80% to $2.28, Ocular Therapeutix Inc. (OCUL) fell 3.14% to $10.49, and Kodiak Sciences Inc. (KOD) fell 6.03% to $100.49. Trading volume (13.0 M) eclipsed its 50-day average volume of 12.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 28, 2021.
(END) Dow Jones Newswires
September 28, 2021 17:13 ET (21:13 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.